Skip to main content
Caplight Logo









Holiferm

Holiferm

Private
ManchesterHealthcare & Life Scienceshttps://holiferm.com

Last Round

Series B

Dec 6, 2023

Total Funding Raised

$34.27M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Holiferm operates in Healthcare & Life Sciences and is based in Manchester. Its latest recorded funding round was a Series B round in December 2023.

Holiferm is a biotechnology company that develops processes for and manufactures innovative, green and sustainable biosurfactants.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Clean Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Holiferm Comparables

Compare Holiferm with similar companies based on industry and business-model similarity.

Holiferm comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biotensidon GmbH
87%
AGAE Technologies
84%
AmphiStar
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Holiferm Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 6, 2023
VC RoundJul 31, 2023
Series ANov 12, 2021
GrantNov 9, 2020
SeedMay 1, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Ben Dolman

CIO And Founder

Founding Team

Charles Dimmler

Chief Executive Officer

Executive Team

Richard L.

Chief Operating Officer, Managing Director

Executive Team

For institutional investors. Book with your work email.

Holiferm Investors

Notable investors and investment history

Holiferm investors
InvestorRounds
Liverpool City Region Local Enterprise PartnershipGrant
ICOS CapitalSeries A, Seed
Rhapsody Venture PartnersSeries B, Series A
Clean Growth Investment ManagementSeries A, Series B
Greater Manchester Combined AuthorityVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 70% MoM.

  • Jun 18, 2026

    Monthly visitors increased 112% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • attends_eventOct 7, 2026

    Holiferm attends SEPAWA congress 2026.

  • is_developingSep 14, 2026

    Holiferm announces a partnership with Organica UK, in collaboration with Sadorp, to develop novel performance biochemicals by combining biosurfactant manufacturing with formulations in United Kingdom on Sep 8th '26.

  • acquiresSep 8, 2026

    On Sep 8th '26, Holiferm acquires Organica UK Ltd in the United Kingdom, combining biosurfactant innovation and manufacturing with formulation and finished-product capabilities to commercialise sustainable cleaning products.

Book a demo to see all news

For institutional investors. Book with your work email.

Holiferm Filings

Explore SEC and related filing metadata, where available.

Holiferm filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Holiferm's valuation, stock price, and market status.

Is Holiferm a public or private company?

Holiferm is a private company.

What is the current stock price of Holiferm?

Holiferm is a private company, so its shares have no public market price. Caplight tracks Holiferm's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Holiferm worth (valuation)?

Valuation information for Holiferm is not publicly available.

Can I buy Holiferm stock?

Holiferm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Holiferm's last funding round?

Holiferm's most recent funding round was Series B on December 6, 2023.

Who are the main investors in Holiferm?

Key investors in Holiferm include ICOS Capital, Rhapsody Venture Partners, Clean Growth Investment Management.

Will Holiferm IPO soon?

No public IPO plans have been announced for Holiferm.

How can I track Holiferm secondary market activity?

Caplight tracks bids, offers, and trades in Holiferm's shares on secondary markets.

Firmographic Details

HeadquartersManchester
Employee Range59
Year Founded2018
Last FundingDec 6, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?